Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2026-05-27 @ 8:24 AM
Study NCT ID:
NCT04934618
Status:
UNKNOWN
Last Update Posted:
2021-06-22
First Post:
2021-06-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of Carelizumab Combined With Irinotecan and Apatinib of Second-line Treatment for Advanced Gastric Cancer
Sponsor:
Nanfang Hospital, Southern Medical University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Gastric Cancer | View |
Keywords: